Press Releases

Received notice for upcoming USDA meetingCompany is reviewing strategic alternatives to monetize OS Animal Health ("OSAH")Grasonville, Maryland--(Newsfile Corp. - October 7, 2026) - OS Therapies, Inc. (NYSE:OSTX) ("OS Therapies" or the "Company"), the world leader in gene-edited, Listeria-based cancer immunotherapies, today announced that its wholly-owned animal health subsidiary, OSAH received feedback from the U.S. Department of Agriculture (USDA) related to its submission to gain alignment on the commercial development pathway for OST-HER2 in the treatment of canine osteosarcoma. USDA provided guidance related to the OSAH's upcoming conditional licensure request in the areas of clinical e

GALWAY, Ireland, Oct. 7, 2026 /PRNewswire/ -- TE Connectivity plc (NYSE:TEL) will report financial results for the fourth quarter and full year of fiscal 2026 before trading begins on October 28, 2026. The company will hold a conference call for investors at 8:30 a.m. ET. The conference call may be accessed in the following ways:At TE Connectivity's website: investors.te.com  By telephone: For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the United States is (833) 461-5787 and for international callers, the dial-in number is (585) 542-9983; meeting ID: 968971220.A replay of the conference ca

A New Corporate Communications Platform Launched in Leifras' 25thAnniversary Year to Share the People, Perspectives and Stories Behind Its Business- First "ITO'S MESSAGE" to Be Published on October 9, Marking the First Anniversary of Leifras' Nasdaq Listing -TOKYO, Oct. 7, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (NASDAQ:LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community engagement, and a leading operator of children's sports schools and school club activity support businesses in Japan, today announced the launch of its official note channel, "Story of LEIFRAS," as a new corporate communications platform in 2026, the year of the Comp

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Employers face a growing workforce risk as employees struggle to understand which skills they need and how to develop them quickly enough to keep pace with changing work, according to WTW’s latest EX Intelligent report. The proportion of employees who say their manager helps develop their abilities has shifted from 84% to 78% over the past four years, highlighting the need to give managers more support for development conversations. At the same time, only about 30% of organizations have established processes for identifying, assessing and tracking workforce skills. This mismatch risks creating "capability anxiety": uncertainty among employees a

The Taiwan FDA approved the amended protocol and the lead Taiwan site received IRB approval during September of 2026. The next stage (Part 2) is a single-arm study enrolling never-smoker patients with the EGFR exon 21 L858R mutation, with LP-300 dosing extended from six to a maximum of eight cycles. EGFR mutations are found in 55% of advanced lung adenocarcinomas in Taiwan and roughly half across Asia, compared with approximately 14% of NSCLC in Europe and 24% in the U.S.; the L858R mutation is also more common in Asian patients. In the U.S., a central IRB has approved the amended protocol and academic sites have begun identifying patients with the L858R mutation for enrollment.

Highlights Include Landmark Agreement with Nebius, Expansion of Power Portfolio, and Funding Strategy for CLT1 NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) --  AIB Data Centers, Inc. (NYSE:AIB) ("AIB" or the "Company"), a developer and operator of digital infrastructure focused on artificial intelligence and high-performance computing workloads, today issued a letter to shareholders from Chief Executive Officer Jerry Tang highlighting the Company’s significant recent progress and outlining its development and funding strategy for CLT1. Recent developments highlighted in the letter include: Execution of a 12-year agreement with Nebius for 50 MW of critical IT capacity at AIB’s CLT1 data cent

 Veteran customer leader joins Commvault to accelerate customer value, resilience, and growth in the AI eraTINTON FALLS, N.J., Oct. 7, 2026 /PRNewswire/ -- Commvault (NASDAQ:CVLT), a leader in unified resilience at enterprise scale, today announced the appointment of Matthew Stauble as Chief Customer Officer, reporting to Geoff Haydon, President of Customer and Field Operations.Stauble will lead the company's global customer engineering organization, spanning sales engineering, customer success, professional services, and customer support, and covering the full customer lifecycle from technical evaluation through adoption, renewal, and expansion.Stauble joins Commvault from Alteryx, a data a

SAN DIEGO, Oct. 7, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme" or the "Company") announced today that the specialized Dutch patent court of the Hague has found Merck to be infringing one of its MDASE patents, EP 2,797,622 (EP622) and ordered Merck's central European Market Authorization Holder and worldwide packaging and distribution hub MSD BV to refrain from manufacturing, having manufactured, offering, placing on the market and using, or importing or stocking for these purposes, Keytruda SC in Belgium, Denmark, France, Ireland, Italy, Sweden, Switzerland and the Netherlands. The injunction also forbids MSD to facilitate infringement by its affiliates, includ

New approach proposes an alternative to repeated injectionsHOUSTON, Oct. 7, 2026 /PRNewswire/ -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced today that it has filed a U.S. patent application covering a new cell-based technology designed to continuously produce peptides such as GLP-1, GIP and GLP-2 inside the body.Today, popular GLP-1 medicines used for weight loss and diabetes generally require patients to take regular weekly injections or daily pills. Fibro

Temab-A is an investigational, next-generation, c-Met-directed antibody-drug conjugate (ADC) with a novel topoisomerase 1 inhibitor (Top1i) being studied in advanced solid tumors including colorectal cancer (CRC) and non-small cell lung cancer (NSCLC)These designations represent the first Breakthrough Therapy Designations (BTDs) for Temab-A and further underscore the strength of AbbVie's ADC portfolio, which now includes four BTDsNORTH CHICAGO, Ill., Oct. 7, 2026 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced that the U.S. Food and Drug Administration (FDA) has granted two Breakthrough Therapy Designations (BTDs) for telisotuzumab adizutecan (Temab-A; ABBV-400) in colorectal cancer (CRC)

CINCINNATI, Oct. 7, 2026 /PRNewswire/ -- Cincinnati Financial Corporation (NASDAQ:CINF) plans to release its third-quarter 2026 results on Monday, October 26, 2026, after the close of regular trading on the Nasdaq Stock Market.The company will hold a conference call to discuss third-quarter 2026 results on Tuesday, October 27, at 11 a.m. ET. To access the call webcast, please visit investors.cinfin.com. A replay will be available approximately two hours after the event's completion.About Cincinnati Financial Corporation: Cincinnati Financial Corporation offers primarily business, home and auto insurance through The Cincinnati Insurance Company and its two standard market property casualty co

KQC helps enterprises put quantum computing and post-quantum cryptography to work through Qubiteer, its AI-driven hybrid quantum platform, access to multiple quantum technologies, and quantum-safe security products Combined company, KQC Quantum, Inc., expected to list on Nasdaq; proceeds to fund product commercialization and the conversion of customer pilots into deployments Transaction Highlights Enterprise quantum, built for adoption. KQC works in the layer between quantum hardware and industry: it defines customer problems, builds the models, runs them on the most suitable classical, quantum or hybrid resource, and integrates the results. Its Qubiteer platform, currently in develo

DigitalBridge Group, Inc. ("DigitalBridge"), a leading global investor in digital infrastructure, today announced that, as a result of its acquisition by affiliates of SoftBank Group Corp. on September 30, 2026 (the "Transaction"), holders of its 7.125% Series H Cumulative Redeemable Perpetual Preferred Stock (the "Series H Preferred Stock") will have the right, until the close of business on October 28, 2026, to convert each share of Series H Preferred Stock into $11.28 in cash (the "Change of Control Conversion Right"). Thereafter, holders of Series H Preferred Stock will no longer have the right to exercise the Change of Control Conversion Right in connection with the Transaction and the

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced the appointment of David Liu, M.D., Ph.D., as Executive Vice President and Chief Medical Officer (CMO), effective October 12, 2026. Dr. Liu will be responsible for leading the clinical development, medical affairs and regulatory affairs functions. "David brings extensive immuno-oncology leadership experience, a strong track record of advancing and securing approvals for innovative cancer therapies and deep expertise in global regulatory strategy and execution," said Marianne De Backer, President and Chief Executive Officer of Vir Biotechnology. "I look forward to partnering with him as we advance our Phase 3 program for chronic hepatitis d

Storewide grocery deployment reports zero fraud and 100% successful activation across more than 90,000 protected cards. Digimarc Corporation (NASDAQ:DMRC), a leading provider of digital identity and authentication technologies, today announced growing adoption of its next generation gift card security solution. More than two dozen major retailers and brands are now exploring, piloting, or deploying the solution, which automatically identifies card tampering and stops compromised cards from activating at the register. Protected cards on shelves today carry top brands across several categories, including open loop bank cards, luxury department stores, and home improvement. "The industry h

Manako’s Vision Agents Now Operating Around the Clock at Avia Xpress Stations Using Existing Camera InfrastructureTaoWeave, Inc. (NASDAQ:TWAV) today announced that Manako Labs Ltd., the Physical AI company in which TaoWeave invested in June 2026, has gone live commercially with Avia Thévenin-Ducrot, a fuel retail group operating Avia stations in France. Manako’s Vision Agents now run around the clock across a first wave of 124 unmanned Avia Xpress stations, and Avia Thévenin-Ducrot has named Manako its lead Physical AI design partner.TaoWeave holds North American commercialization rights to Manako’s platform and participates in revenue generated through licensing agreements originated by the

Agreement provides access to 4,400 U.S. hospitals and health systems and provides Premier members pre-negotiated pricing and terms QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its U.S. distribution partner, NXC Imaging, Inc., a wholly owned subsidiary of Canon Medical Systems USA, Inc., has entered into a national group purchasing agreement with Premier, Inc. covering the QTI Breast Acoustic CT™ scanner and providing access to nearly 4,400 hospitals and health systems nationwide. The agreement allows eligible P

Second Recent Three-Year Award from Customer Expands Long-Standing Relationship Across Additional Location Trio-Tech International (NASDAQ:TRT), a comprehensive provider of semiconductor back-end solutions and a global value-added supplier of electronic equipment, today announced it has secured a new three-year contract valued at approximately $4.45 million to provide burn-in testing equipment and ongoing technical and maintenance support to an existing European automotive semiconductor customer. The new award is a separate contract from the three-year production burn-in services agreement Trio-Tech announced on September 17, 2026, and further expands a long-standing customer relationsh

New GUARDIAN data demonstrates strong parent participation, consistent sequencing performance across diverse ancestries and actionable insights for newborns and families Data from BRIDGES-NBS shows an expert-informed approach to broadening the number of actionable conditions appropriate for gNBS GeneDx (NASDAQ:WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced new findings to be presented at the International Consortium on Newborn Sequencing (ICoNS), October 7-8 in Boston, demonstrating progress toward making genomic newborn screening (gNBS) a scalable and accessible part of proactive healthcare. As a sequencing and inter

Shark® Rocket® Turbo tackles everyday messes and pet hair, while Shark Detect™ + Reveal adds Direction Detect and Reveal Technology to help find and remove hidden debrisSharkNinja, Inc. (NYSE:SN), a global product design and technology company, expanded its corded stick vacuum lineup with the Shark® Rocket® Turbo Corded Stick Vacuum and Shark Detect™ + Reveal Corded Stick Vacuum. Both combine powerful suction with a self-cleaning brushroll and unlimited corded runtime for cleaning carpets and hard floors.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261007579502/en/The Shark Detect™ + Reveal uses Direction Detect to automatically